Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication Market Perspective (2018-2029)
2.2 Medication Growth Trends by Region
2.2.1 Global Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medication Historic Market Size by Region (2018-2024)
2.2.3 Medication Forecasted Market Size by Region (2024-2029)
2.3 Medication Market Dynamics
2.3.1 Medication Industry Trends
2.3.2 Medication Market Drivers
2.3.3 Medication Market Challenges
2.3.4 Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication Players by Revenue
3.1.1 Global Top Medication Players by Revenue (2018-2024)
3.1.2 Global Medication Revenue Market Share by Players (2018-2024)
3.2 Global Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medication Revenue
3.4 Global Medication Market Concentration Ratio
3.4.1 Global Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2022
3.5 Medication Key Players Head office and Area Served
3.6 Key Players Medication Product Solution and Service
3.7 Date of Enter into Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Breakdown Data by Type
4.1 Global Medication Historic Market Size by Type (2018-2024)
4.2 Global Medication Forecasted Market Size by Type (2024-2029)
5 Medication Breakdown Data by Application
5.1 Global Medication Historic Market Size by Application (2018-2024)
5.2 Global Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medication Market Size (2018-2029)
6.2 North America Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medication Market Size by Country (2018-2024)
6.4 North America Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medication Market Size (2018-2029)
7.2 Europe Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medication Market Size by Country (2018-2024)
7.4 Europe Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication Market Size (2018-2029)
8.2 Asia-Pacific Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medication Market Size by Region (2018-2024)
8.4 Asia-Pacific Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medication Market Size (2018-2029)
9.2 Latin America Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medication Market Size by Country (2018-2024)
9.4 Latin America Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication Market Size (2018-2029)
10.2 Middle East & Africa Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medication Market Size by Country (2018-2024)
10.4 Middle East & Africa Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medication Introduction
11.1.4 Pfizer Revenue in Medication Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Medication Introduction
11.2.4 Roche Revenue in Medication Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Medication Introduction
11.3.4 Sanofi Revenue in Medication Business (2018-2024)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Medication Introduction
11.4.4 Johnson & Johnson Revenue in Medication Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Medication Introduction
11.5.4 Merck & Co. (MSD) Revenue in Medication Business (2018-2024)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Medication Introduction
11.6.4 Novartis Revenue in Medication Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Medication Introduction
11.7.4 AbbVie Revenue in Medication Business (2018-2024)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Medication Introduction
11.8.4 Gilead Sciences Revenue in Medication Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Medication Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2018-2024)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Medication Introduction
11.10.4 Amgen Revenue in Medication Business (2018-2024)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Medication Introduction
11.11.4 AstraZeneca Revenue in Medication Business (2018-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Medication Introduction
11.12.4 Bristol-Myers Squibb Revenue in Medication Business (2018-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Medication Introduction
11.13.4 Eli Lilly Revenue in Medication Business (2018-2024)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Medication Introduction
11.14.4 Teva Revenue in Medication Business (2018-2024)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Medication Introduction
11.15.4 Bayer Revenue in Medication Business (2018-2024)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Medication Introduction
11.16.4 Novo Nordisk Revenue in Medication Business (2018-2024)
11.16.5 Novo Nordisk Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Medication Introduction
11.17.4 AbbVie Revenue in Medication Business (2018-2024)
11.17.5 AbbVie Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Medication Introduction
11.18.4 Takeda Revenue in Medication Business (2018-2024)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Medication Introduction
11.19.4 Boehringer Ingelheim Revenue in Medication Business (2018-2024)
11.19.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Medication Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Medication Market Share by Region (2018-2024)
Table 8. Global Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Medication Market Share by Region (2024-2029)
Table 10. Medication Market Trends
Table 11. Medication Market Drivers
Table 12. Medication Market Challenges
Table 13. Medication Market Restraints
Table 14. Global Medication Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Medication Market Share by Players (2018-2024)
Table 16. Global Top Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2022)
Table 17. Ranking of Global Top Medication Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Medication Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medication Product Solution and Service
Table 21. Date of Enter into Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medication Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Medication Revenue Market Share by Type (2018-2024)
Table 25. Global Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Medication Revenue Market Share by Type (2024-2029)
Table 27. Global Medication Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Medication Revenue Market Share by Application (2018-2024)
Table 29. Global Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Medication Revenue Market Share by Application (2024-2029)
Table 31. North America Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Medication Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Medication Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Medication Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Medication Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Medication Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Medication Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Medication Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Medication Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Medication Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Medication Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Medication Product
Table 49. Pfizer Revenue in Medication Business (2018-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Medication Product
Table 54. Roche Revenue in Medication Business (2018-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Medication Product
Table 59. Sanofi Revenue in Medication Business (2018-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Medication Product
Table 64. Johnson & Johnson Revenue in Medication Business (2018-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Merck & Co. (MSD) Company Detail
Table 67. Merck & Co. (MSD) Business Overview
Table 68. Merck & Co. (MSD) Medication Product
Table 69. Merck & Co. (MSD) Revenue in Medication Business (2018-2024) & (US$ Million)
Table 70. Merck & Co. (MSD) Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Medication Product
Table 74. Novartis Revenue in Medication Business (2018-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Medication Product
Table 79. AbbVie Revenue in Medication Business (2018-2024) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Medication Product
Table 84. Gilead Sciences Revenue in Medication Business (2018-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. GlaxoSmithKline (GSK) Company Detail
Table 87. GlaxoSmithKline (GSK) Business Overview
Table 88. GlaxoSmithKline (GSK) Medication Product
Table 89. GlaxoSmithKline (GSK) Revenue in Medication Business (2018-2024) & (US$ Million)
Table 90. GlaxoSmithKline (GSK) Recent Development
Table 91. Amgen Company Detail
Table 92. Amgen Business Overview
Table 93. Amgen Medication Product
Table 94. Amgen Revenue in Medication Business (2018-2024) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Medication Product
Table 99. AstraZeneca Revenue in Medication Business (2018-2024) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Bristol-Myers Squibb Company Detail
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Medication Product
Table 104. Bristol-Myers Squibb Revenue in Medication Business (2018-2024) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Medication Product
Table 109. Eli Lilly Revenue in Medication Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Teva Company Detail
Table 112. Teva Business Overview
Table 113. Teva Medication Product
Table 114. Teva Revenue in Medication Business (2018-2024) & (US$ Million)
Table 115. Teva Recent Development
Table 116. Bayer Company Detail
Table 117. Bayer Business Overview
Table 118. Bayer Medication Product
Table 119. Bayer Revenue in Medication Business (2018-2024) & (US$ Million)
Table 120. Bayer Recent Development
Table 121. Novo Nordisk Company Detail
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Medication Product
Table 124. Novo Nordisk Revenue in Medication Business (2018-2024) & (US$ Million)
Table 125. Novo Nordisk Recent Development
Table 126. AbbVie Company Detail
Table 127. AbbVie Business Overview
Table 128. AbbVie Medication Product
Table 129. AbbVie Revenue in Medication Business (2018-2024) & (US$ Million)
Table 130. AbbVie Recent Development
Table 131. Takeda Company Detail
Table 132. Takeda Business Overview
Table 133. Takeda Medication Product
Table 134. Takeda Revenue in Medication Business (2018-2024) & (US$ Million)
Table 135. Takeda Recent Development
Table 136. Boehringer Ingelheim Company Detail
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Medication Product
Table 139. Boehringer Ingelheim Revenue in Medication Business (2018-2024) & (US$ Million)
Table 140. Boehringer Ingelheim Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Medication Market Share by Type: 2022 VS 2029
Figure 3. Brand Drugs Features
Figure 4. Generic Drug Features
Figure 5. Global Medication Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Medication Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Medication Report Years Considered
Figure 11. Global Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medication Market Share by Region: 2022 VS 2029
Figure 14. Global Medication Market Share by Players in 2022
Figure 15. Global Top Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Medication Revenue in 2022
Figure 17. North America Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Medication Market Share by Country (2018-2029)
Figure 19. United States Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Medication Market Share by Country (2018-2029)
Figure 23. Germany Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Medication Market Share by Region (2018-2029)
Figure 31. China Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Medication Market Share by Country (2018-2029)
Figure 39. Mexico Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Medication Market Share by Country (2018-2029)
Figure 43. Turkey Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Medication Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Medication Business (2018-2024)
Figure 47. Sanofi Revenue Growth Rate in Medication Business (2018-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Medication Business (2018-2024)
Figure 49. Merck & Co. (MSD) Revenue Growth Rate in Medication Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Medication Business (2018-2024)
Figure 51. AbbVie Revenue Growth Rate in Medication Business (2018-2024)
Figure 52. Gilead Sciences Revenue Growth Rate in Medication Business (2018-2024)
Figure 53. GlaxoSmithKline (GSK) Revenue Growth Rate in Medication Business (2018-2024)
Figure 54. Amgen Revenue Growth Rate in Medication Business (2018-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Medication Business (2018-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Medication Business (2018-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Medication Business (2018-2024)
Figure 58. Teva Revenue Growth Rate in Medication Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Medication Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Medication Business (2018-2024)
Figure 61. AbbVie Revenue Growth Rate in Medication Business (2018-2024)
Figure 62. Takeda Revenue Growth Rate in Medication Business (2018-2024)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Medication Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed